CLINICAL_TRIALS
research
· 2024-12-27
Clinical Trial Update: A Study of Efficacy and Safety of TLL-018 in CSU Participants [Phase 3]
Summary
Phase 3 clinical trial update for TLL-018 in chronic spontaneous urticaria, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd | Conditions: Chronic Spontaneous Urticaria | Phase 3 | Status: RECRUITING